Hazem El Gamal, MD
MOHS-Micrographic Surgery · Charlotte, NCNPI 1720027246
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 31.4% of the total. Reporting peaked in 2023 at $557 and has fallen 91.0% since, to $50 in 2025.
Across 87 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$508
- Sanofi$112
- Sun Pharmaceutical Industries Inc.$102
- Amgen$95
- Regeneron Healthcare Solutions, Inc.$81
- Fresenius Kabi USA, LLC$73
- plus $648 from 21 others
What the payments were for
- Food & beverage$1,619100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $508 |
| Sanofi | 5 | $112 |
| Sun Pharmaceutical Industries Inc. | 6 | $102 |
| Amgen | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| Fresenius Kabi USA, LLC | 3 | $73 |
| Pfizer | 6 | $70 |
| E.r. Squibb & Sons, L.L.C. | 4 | $66 |
| Convatec Inc. | 3 | $56 |
| LEO Pharma Inc. | 3 | $51 |
| Galderma Laboratories, L.p. | 3 | $49 |
| Organogenesis Inc. | 2 | $45 |
| Kerecis Limited | 2 | $39 |
| Almirall LLC | 2 | $34 |
| Novartis | 2 | $28 |
| Triad Life Sciences Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| AstraZeneca | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Botanix SB Inc | 1 | $15 |
| Biofrontera Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| DUSA Pharmaceuticals, Inc. | 1 | $13 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$1,619 in reported general payments places this provider in the 55th percentile of 50 mohs-micrographic surgery providers in North Carolina.
See all mohs-micrographic surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 1,097 | $3,769 |
| Clobetasol Propionate | 55 | $2,402 |
| Triamcinolone Acetonide | 159 | $1,625 |
| Doxycycline Hyclate | 123 | $1,201 |
| Ketoconazole | 75 | $1,082 |
| Metronidazole | 13 | $736 |
| Azithromycin | 94 | $311 |
| Ciprofloxacin Hcl | 34 | $134 |
| Hydrocortisone | 19 | $122 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $102 |
| Tramadol Hcl | 24 | $70 |
| Levofloxacin | 16 | $58 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Charlotte
- Girish MunavalliCharlotte$118K
- Laura RosenzweigCharlotte$27K
- David LaneCharlotte$14K
- Sasha HaberleCharlotte$4K
- Euphemia MuCharlotte$4K
- Jonathan OlsonCharlotte$4K
- Matthew ClarkCharlotte$2K
- Lauren JenkinsCharlotte$1K
- Eric ChallgrenRaleigh$47K
- Timothy FlynnCary$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.